Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
| Autor: | Poveda, A., Lheureux, S., Colombo, N., Cibula, D., Lindemann, K., Weberpals, J., Bjurberg, M., Oaknin, A., Sikorska, M., González-Martín, A., Madry, R., Pérez, M.J. Rubio, Ledermann, J., Davidson, R., Blakeley, C., Bennett, J., Barnicle, A., Škof, E. |
|---|---|
| Zdroj: | In Gynecologic Oncology March 2022 164(3):498-504 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect